SynopsisPegaspargase is a modified enzyme used as an antineoplastic agent. It is a form of L-asparaginase which has undergone PEGylation. The global Pegaspargase Drugs market size is expected to reach US$ 505.9 million by 2029, growing at a CAGR of 8.2% from 202.....
SynopsisMercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. The global Mercaptopurine Oral Solution market size is expected to reach US$ 62.....
SynopsisMercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. The global Mercaptopurine Oral Solution Drugs market size is expected to reach .....
SynopsisMercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. The global Purixan market size is expected to reach US$ 667.1 million by 2029, .....
SynopsisMercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. The global Mercaptopurine market size is expected to reach US$ 627.3 million by.....
SynopsisMercaptopurine, a nucleoside metabolic inhibitor, known chemically as 1,7-dihydro-6H-purine-6-thione monohydrate, is an analogue of the purine bases adenine and hypoxanthine. The global Mercaptopurine Drugs market size is expected to reach US$ 627.3 mill.....
SynopsisDasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The global Dasatinib Drugs market size is expected to reach US$ million b.....
SynopsisDasatinib, sold under the brand name Sprycel, is a chemotherapy medication used to treat certain cases of chronic myelogenous leukemia (CML) and acute lymphoblastic leukemia (ALL). The global Sprycel market size is expected to reach US$ 514.6 million by .....
SynopsisMethotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions. The global Methotrexate Oral Solution market size.....
SynopsisMethotrexate (MTX), formerly known as amethopterin, is a chemotherapy agent and immune system suppressant.[1] It is used to treat cancer, autoimmune diseases, ectopic pregnancy, and for medical abortions. The global Methotrexate Oral Solution Drugs marke.....








